Planning and evaluation activities of the Koch Institute are under the purview of the Senior Leadership, the Koch Institute Executive Committee and Scientific Advisory Board as well as the Administrative staff. In addition, the Koch Institute is also linked to review and planning mechanisms of MIT. Policies and specific decisions about scientific planning, hiring, membership, and the use of CCSG and other funds are made after consultation with the broader Membership. In his role as Director, Dr. Jacks receives critical support from Senior Leadership consisting of Associate Directors, Drs. Lees and Wittrup, and the Assistant Director for Administration, Ms. Quense. Dr. Jacks meets regularly with the Koch Institute Executive Committee, comprised of Senior Leadership members and other Program Leaders (Drs. Amon, Bhatia, Hynes, Langer, Sharp, Wittrup, and Yaffe). These individuals bring a wealth of administrative experience to the leadership structure of the Koch Institute. In addition, the there is an active Scientific Advisory Board, which plays a critical advising role the Director and Center Leadership. MIT evaluation of the research, shared resources, administration and operating structure of the Koch Institute occurs via several processes. Formal internal MIT evaluation processes include an annual report by the Koch Institute Director to the President of MIT and an annual report and budget meeting with the Vice President for Research. The Koch Institute is also subject to review by the Visiting Committee of the Department of Biology, which is appointed by the MIT Corporation and is made up of prominent scientists from outside of MIT and individuals from industry. The most recent Visiting Committee meeting was held in spring 2013. These evaluations are used in determining financial support and space allocations by MIT to the KI; both have increased over the last grant period, reflecting the strong reputation and status of the Koch Institute within MIT. The Koch Institute has several additional means of planning and evaluation. Principal among these are the Koch Institute Annual Retreat and bi-weekly Koch Institute CCSG Program and Faculty Meetings. The annual off-site retreats have proven to be an excellent opportunity for Koch Institute members and their laboratories to engage with each other and discuss their science, formally and informally. They are also very useful for the Koch Institute leadership to evaluate the Programs and membership as a whole; in recent years, the retreats have also been used as a mechanism to evaluate the candidacy of potential Koch Institute members. In addition, the Koch Institute members meet approximately every two weeks during the academic year to discuss scientific developments, Koch Institute business, and future directions. Strong mechanisms for ongoing review of Koch Institute Core Facilities are in place to ensure scientific needs of the Center members are met.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014051-47
Application #
9487925
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
47
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
Tentori, Augusto M; Nagarajan, Maxwell B; Kim, Jae Jung et al. (2018) Quantitative and multiplex microRNA assays from unprocessed cells in isolated nanoliter well arrays. Lab Chip 18:2410-2424
Parisi, Tiziana; Balsamo, Michele; Gertler, Frank et al. (2018) The Rb tumor suppressor regulates epithelial cell migration and polarity. Mol Carcinog 57:1640-1650
Gam, Jeremy J; Babb, Jonathan; Weiss, Ron (2018) A mixed antagonistic/synergistic miRNA repression model enables accurate predictions of multi-input miRNA sensor activity. Nat Commun 9:2430
Chen, Huihui; Cho, Kin-Sang; Vu, T H Khanh et al. (2018) Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma. Nat Commun 9:3209
Tam, Brooke E; Hao, Yining; Sikes, Hadley D (2018) An examination of critical parameters in hybridization-based epigenotyping using magnetic microparticles. Biotechnol Prog 34:1589-1595
Ramadi, Khalil B; Dagdeviren, Canan; Spencer, Kevin C et al. (2018) Focal, remote-controlled, chronic chemical modulation of brain microstructures. Proc Natl Acad Sci U S A 115:7254-7259
Knouse, Kristin A; Lopez, Kristina E; Bachofner, Marc et al. (2018) Chromosome Segregation Fidelity in Epithelia Requires Tissue Architecture. Cell 175:200-211.e13
Sabari, Benjamin R; Dall'Agnese, Alessandra; Boija, Ann et al. (2018) Coactivator condensation at super-enhancers links phase separation and gene control. Science 361:
Fiedler, Eleanor R C; Bhutkar, Arjun; Lawler, Emily et al. (2018) In vivo RNAi screening identifies Pafah1b3 as a target for combination therapy with TKIs in BCR-ABL1 + BCP-ALL. Blood Adv 2:1229-1242
Clancy-Thompson, Eleanor; Devlin, Christine A; Tyler, Paul M et al. (2018) Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell-Effector Responses. Cancer Immunol Res 6:1524-1536

Showing the most recent 10 out of 904 publications